版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
WHOLOTTESTINGPROGRAMMEFORMALARIARAPIDDIAGNOSTICTESTS(RDTs)
2007–2022
WHOLOTTESTINGPROGRAMMEFORMALARIARAPIDDIAGNOSTICTESTS(RDTs)
2007–2022
WHO/UCN/GMP/2023.04
?WorldHealthOrganization2023
Somerightsreserved.ThisworkisavailableundertheCreativeCommonsAttribution-NonCommercial-ShareAlike3.0IGOlicence(CCBY-NC-SA3.0IGO;/licenses/by-nc-sa/3.0/igo).
Underthetermsofthislicence,youmaycopy,redistributeandadapttheworkfornon-commercialpurposes,providedtheworkisappropriatelycited,asindicatedbelow.Inanyuseofthiswork,thereshouldbenosuggestionthatWHOendorsesanyspecificorganization,productsorservices.TheuseoftheWHOlogoisnotpermitted.Ifyouadaptthework,thenyoumustlicenseyourworkunderthesameorequivalentCreativeCommonslicence.Ifyoucreateatranslationofthiswork,youshouldaddthefollowingdisclaimeralongwiththesuggestedcitation:“ThistranslationwasnotcreatedbytheWorldHealthOrganization(WHO).WHOisnotresponsibleforthecontentoraccuracyofthistranslation.TheoriginalEnglisheditionshallbethebindingandauthenticedition”.
AnymediationrelatingtodisputesarisingunderthelicenceshallbeconductedinaccordancewiththemediationrulesoftheWorldIntellectualPropertyOrganization
(/amc/en/mediation/rules/
).
Suggestedcitation.WHOlottestingprogrammeformalariarapiddiagnostictests(RDTs),2007–2022.Geneva:WorldHealthOrganization;2023(WHO/UCN/GMP/2023.04).Licence:
CCBY-NC-SA3.0IGO
.
Cataloguing-in-Publication(CIP)data.CIPdataareavailableat
/iris
.
Sales,rightsandlicensing.TopurchaseWHOpublications,see/publications/book-
orders.Tosubmitrequestsforcommercialuseandqueriesonrightsandlicensing,see
/copyright
.
Third-partymaterials.Ifyouwishtoreusematerialfromthisworkthatisattributedtoathirdparty,suchastables,figuresorimages,itisyourresponsibilitytodeterminewhetherpermissionisneededforthatreuseandtoobtainpermissionfromthecopyrightholder.Theriskofclaimsresultingfrominfringementofanythird-party-ownedcomponentintheworkrestssolelywiththeuser.
Generaldisclaimers.ThedesignationsemployedandthepresentationofthematerialinthispublicationdonotimplytheexpressionofanyopinionwhatsoeveronthepartofWHOconcerningthelegalstatusofanycountry,territory,cityorareaorofitsauthorities,orconcerningthedelimitationofitsfrontiersorboundaries.Dottedanddashedlinesonmapsrepresentapproximateborderlinesforwhichtheremaynotyetbefullagreement.
Thementionofspecificcompaniesorofcertainmanufacturers’productsdoesnotimplythattheyareendorsedorrecommendedbyWHOinpreferencetoothersofasimilarnaturethatarenotmentioned.Errorsandomissionsexcepted,thenamesofproprietaryproductsaredistinguishedbyinitialcapitalletters.
AllreasonableprecautionshavebeentakenbyWHOtoverifytheinformationcontainedinthispublication.However,thepublishedmaterialisbeingdistributedwithoutwarrantyofanykind,eitherexpressedorimplied.Theresponsibilityfortheinterpretationanduseofthemateriallieswiththereader.InnoeventshallWHObeliablefordamagesarisingfromitsuse.
CONTENTS
ABOUT1
MALARIARDTLOTTESTINGRESULTS,2022(INITIALTESTING)2
MALARIARDTLOTTESTINGRESULTS,2022(NON-ROUTINETESTING)3
MALARIARDTLOTTESTINGRESULTS,2007–2022(CUMULATIVESUMMARYBYPRODUCT)4
MALARIARDTLOTTESTINGRESULTSSUMMARY,2007–202210
PRE-QUALIFIEDPRODUCTSSUBMITTEDFORMALARIARDTLOT-TESTING,202211
ANNUALDEMANDFORMALARIARDTLOTTESTING,2007-202212
REQUESTERSANDRECIPIENTCOUNTRIESOFLOT-TESTEDMALARIARDTs,202214
WHOLOTTESTINGPROGRAMMEFORMALARIARAPIDDIAGNOSTICTESTS(RDTs),(20072022)1
ABOUT
TheWHOlottestingprogrammeformalariarapiddiagnostictests(RDTs)isanindependentqualitycontrolsystemdesignedtoevaluatelottolotvariationinperformanceofmalariaRDTs.ThepurposeofthisprogrammeistoensurethatonlythehighestqualitymalariaRDTlotsareprocuredandusedinendemiccountries.Currently,theResearchInstituteforTropicalMedicine(RITM)(Philippines)servesastheonlyWHO-sponsoredandmonitoredlaboratoryevaluatingRDTlotsaccordingtoWHOprocedures,usingwell-characterizedandstandardizedparasitesamplesforqualitycontrolofmalariaRDTs.Historically,WHOhascommissionedindependent,externalqualitylaboratoryassessmentsoftheNationalInstituteofMalariaResearch(NIMR),NewDelhi,IndiaandtheANDICentreofExcellenceforMalariaDiagnosis,UniversityofLagos,NigeriaandtheselaboratorieshavebeenfoundtobecompliantwithWHOmalariaRDTlottestingstandardoperatingprocedures.TheselaboratoriesconductlotverificationforRDTbatchesimportedintotheirrespectivecountriesandtheyarenotaccountedforinthisreport.Representativesfromtheselaboratoriesshouldbecontactedforinformationregardingtheir
ongoingcompliancewithWHOproceduresandavailabilityoflottestingservices(India:
nks.nimr@;Nigeria:
andimalariacentre@.ng
).
RDTsaresentfromanywhereintheworldtoRITMonrequestbyMinistriesofHealth,nationalmalariacontrolprogrammes,NGOs,RDTmanufacturers,procurementagenciesandother
internationalorganizations.LottestingisperformedatRITMaccordingtoproceduresoutlined
MethodsManualforLaboratoryQualityControlTestingofMalariaRDTs()
.RDTlotsare
testedwithinfourteendaysofreceipt.MalariaRDTlottestingresultsprovideinformationaboutadequacyofRDTsforclinicaluse,andanomaliesnotedduringtestingthatcanalsobeencounteredduringuseinthefield.ReportsprovidedtolottestingrequestersincludephotosoftheRDTstested,observations(e.g.,redbackground,fainttestline,invalidresult,etc.),andresultsoftheaccessoryassessment.
ThisreportisupdatedannuallybythestaffoftheMalariaRDTLotTestingLaboratory,Research
InstituteforTropicalMedicine(RITM),Philippines(
ritm.malariardtlt@
)andreviewedbytheresponsibleWHOtechnicalofficer
(malaria_rdt@
).Furtherinformationabout
procedurestorequestRDTlottestingservicesaswellasotherrelatedresourcesareavailable
at
GlobalMalariaProgramme().
WHOLOTTESTINGPROGRAMMEFORMALARIARAPIDDIAGNOSTICTESTS(RDTs),(20072022)2
MALARIARDTLOTTESTINGRESULTS,2022
(INITIALTESTING)
ProductNames
CatalogNo.
Manufacturer
No.of
lots
tested
No.oflotspassed
AdvDxMalariaPfRapidMalariaAgDetectionTest
00-DKM-RK-MAL-ADX-004-024
AdvyChemicalPvt.Ltd.
12
11
BiocreditMalariaAg.P.f/P.v(pLDH/pLDH)
C61RHF25
Rapigen,Inc.
2
2
BiolineMalariaAgPf
05FK50
AbbottDiagnosticsKorea,
Inc.
13
13
BiolineMalariaAgPfPOCT
05FK53
4
4
BiolineMalariaAg.P.f/P.f/P.v
05FK63
9
9
BiolineMalariaAg.P.f/P.v
05FK83
1
1
BiolineMalariaAg.P.f/Pan
05FK60
3
3
EzDxMalariaPan/PfRapidTestDetectionKit
00-DKM-RK-MAL-EDX-001-025
AdvyChemicalPvt.Ltd.
1
0
FalciVaxDeviceRapidTestforMalariaPv/Pf
503010025
ZephyrBiomedicals
1
1
FirstResponseMalariaAgP.falciparum(HRP2)CardTest
PI13FRC25
PremierMedicalCorporationPvt.Ltd.
81
81
FirstResponseMalariaAgPf/PvCardTest
PI19FRC25
12
12
FirstResponseMalariaAgpLDH/HRP2ComboCardTest
PI16FRC25
30
30
PI16FRC25CE
3
3
PI16FRC25s
1
1
MeriscreenMalariaP.f/P.vAg
MFLRPD-03
MerilDiagnostics,Pvt.Ltd.
3
3
ParacheckPfDevice-RapidTestforP.falciparumMalaria(Ver3)
302030010
OrchidBiomedicalSystems
20
20
302030025
57
57
ParaHITf.ver1.0RapidTestforP.falciparumMalariaDevice
55IC104-25
ArkrayHealthcarePvt.Ltd.
74
74
55IC104-10
10
10
ParascreenDeviceRapidTestforMalariaPAN/Pf
503030025
ZephyrBiomedicals
6
6
SDBiolineMalariaAgP.f/P.vPOCT
05FK83
StandardDiagnostics,Inc.
1
1
STANDARDQMalariaPfAg
09MAL10D
SDBiosensor,Inc.
2
2
STANDARDQMalariaPf/PANAg
09MAL30D
3
3
STANDARDQMalariaPf/PvAg
09MAL20D
1
1
TOTAL
350
348
WHOLOTTESTINGPROGRAMMEFORMALARIARAPIDDIAGNOSTICTESTS(RDTs),(20072022)3
MALARIARDTLOTTESTINGRESULTS,2022
(NON-ROUTINETESTING)
Atotalof23lotswerereceivedfornon-routinetesting.Sixteen(16)oftheseweresenttotheRITMfortestingafterbeingretrievedfromfieldsitesinRwanda(6lots)andhealthfacilitiesinMalawi(10lots)duetocomplaintsontheirperformance.Twoofthe6lotsfromRwandafailedtheQCassessmentduetoinsufficientbufferwhichdidnotallowtesting.ConcerninglotsthatoriginatedfromMalawi,9outof10lotspassedtheQCassessment;1lotreturnedfalsepositiveresults(3/13)onnegativeQCsamples.
Theother7lotswereforconfirmatorytestingafterdeferredQCassessmentresultsfromNIMR,India.Four(4)ofthe7lotsobtainedfailedQCassessmentresultsintheconfirmatorytestingbecausethelotsshowednegativeresultsonPfQCsamples(3/4samples),consistentwiththeprimarytestingresultsfromNIMR.
ProductNames
CatalogNo.
Manufacturer
No.oflotstested
No.oflotspassed
AdvantageMALCard
IRI21050
DiagnosticEnterprises
1
0
ErbaQik?MalariaPANAntigenTest
132213
TransasiaBio-MedicalsLimited
3
0
EdgeXpressMalariaPanAntigenDetectionTest
EL011C25
EdgeLabsLLP
3
3
SDBiolineMalariaAgP.f/PANPOCT
05FK67
StandardDiagnosticsInc.
6
4
FirstResponseMalariaAg.P.falciparum(HRP2)CardTest
PI13FRC25
PremierMedicalCorporationPrivateLimited
10
9
TOTAL
23
16
WHOLOTTESTINGPROGRAMMEFORMALARIARAPIDDIAGNOSTICTESTS(RDTs),(20072022)4
MALARIARDTLOTTESTINGRESULTS,2007–2022(Cumulativesummarybyproduct)
Manufacturer
CatalogueNo.
Productname
No.
lotstested
Year(s)tested
Pass
Ratet
(%)
Comment
(s)
AbbottDiagnosticsKorea,Inc.
05FK50/53
BiolineMalariaAgPf
39
2021
100
AbbottDiagnosticsKorea,Inc.
05FK60/63
BiolineMalariaAgPf/PAN
22
2021
100
AbbottDiagnosticsKorea,Inc.
05FK83
BiolineMalariaAg.P.f/P.v
1
2022
AbbottDiagnosticsKorea,Inc.
05FK123
BiolineMalariaAg.P.f/P.f/P.v
9
2022
AccessBioInc.
RMLC-02571/RMLM-02571(G0121)
CareStart?MalariaPf/PAN(pLDH)AgRDT
11
2008-2009-
2016-2017
91
1lotfailed
initial
testingin
2016
AccessBioInc.
RMOM-02571/RMOU-02571(G0141/141-SK)
CareStart?MalariaPf(HRP2)AgRDT
866
2010-2011-
2012-2013-
2014-2015-
2016-2017-
2018-2019-2021
100
AccessBioInc.
RMRM-01071/RMRM-02571/RMRU-02571(G0131/131-SK)
CareStart?MalariaPf/PAN
(HRP2/pLDH)Ag
ComboRDT
349
2007-2008-
2009-2010-
2011-2012-
2013-2014-
2015-2016-
2017-2018-
2019-2021
98
6lotsfailed
initial
testingin
2016
AccessBioInc.
RMVM-01071/RMVM-02571/RMVC-02571(G0161)
CareStart?MalariaPf/Pv(HRP2/pLDH)AgComboRDT
57
2012-2013-
2014-2015-
2016-2017-
2018-2019-2021
100
AccessBioInc.
RMWM-02571
CareStart?MalariaPf/VOM
(HRP2/pLDH)Ag
ComboRDT
2
2018
100
AccessBioInc.
G0221
CareStart?Malaria/PregnancyCombo
(HRP2/pLDH/HCG)
1
2015
100
AccessBioInc.
G0231
CareStart?MalariaScreen
16
2008-2009
100
AccessBioInc.
RMNM-02571/RMNC-02571(G0111)
CareStart?MalariapLDH(Pan)
64
2011-2014-
2015-2016-
2017-2018-
2019-2021
100
AccessBioInc.
RMPC-02571
(G0181/181-
ET/181-SK)
CareStart?MalariaHRP2/pLDH(Pf)
37
2013-2014-
2015-2016
100
AdvyChemical
PrivateLimited
RKMAL001
EzDx?MalariaPan/PfRapidtestdetectionKit
9
2011-2013
100
WHOLOTTESTINGPROGRAMMEFORMALARIARAPIDDIAGNOSTICTESTS(RDTs),(20072022)5
Manufacturer
CatalogueNo.
Productname
No.
lotstested
Year(s)tested
Pass
Ratet
(%)
Comment
(s)
AdvyChemical
PrivateLimited
RKMAL003
EzDx?Malaria
Pv/PfRapidMalariaantigendetectiontest
2
2013
100
AdvyChemical
PrivateLimited
00-DKM-RK-MAL-ADX-004-025
AdvDx?MalariaPfRapidMalariaAgDetectionTest
24
2020-2021-2022
96
1lotfailedinitialtestingin2022.
AdvyChemical
PrivateLimited
00-DKM-RK-MAL-EDX-001-025
EzDxMalariaPan/PfRapidTestDetectionKit
1
2022
1
ARKRAYHealthcarePvtLtd*
55IC104-10/25/50
Parahit?fVer1.0RapidTestforP.falciparumMalaria-Device
199
2013-2014-
2015-2016-
2017-2018-
2019-2020-
2021-2022
100
ARKRAYHealthcarePvtLtd*
55IC102-10
ParaHIT-f(device)
7
2007-2009
100
ARKRAYHealthcarePvtLtd*
55IC201-10
ParaHIT-Total
(dipstick)
1
2008
0
1lotfailedinitialtestingin2008
ArtronLaboratoriesInc.
A03-18-322
MalariaPf./Pan
Antigen(MAL
Pf/Pan)TestKit
1
2016
100
ArtronLaboratories,Inc.
A03-12-322
MalariaP.f/Pv(MalPf/Pv)AntigenTestKit
1
2016
100
Athenese-DxPvt.Ltd.
AR0112C
TRUSTlineMalariaPf/PvAg
1
2021
100
BioFootprintsHealthcarePvt.Ltd.
MTR00250
Mytest?MalariaAgPf/Pan
2
2015
100
BioNoteInc.Korea
RG19-11
BionoteMalariaP.fAgRapidTestKit
2
2015
100
BioNote,Inc.
RG19-08
BIONOTEMALARIAP.f&PanAgRapidTestKit
1
2014
100
Clearview
VB11
ClearviewMalariaCombo
1
2010
100
CTKBiotech,Inc.
R0112C
OnSiteMalariaPf/PvAgRapidTest
8
2013-2014
100
CTKBiotech,Inc.
R0113C
OnSiteMalaria
Pf/PanAgRapid
Test
1
2012
100
CTKBiotech,Inc.
R0114C
OnSiteMalariaPfAgRapidTest
6
2007-2013-2014
100
DeangelBiologicalEngineeringCo.,Ltd.
MAL-MD02
MalariaPf/PanRapidTestDevice
2
2015-2017
100
DeangelBiologicalEngineeringCo.,Ltd.
MAL-ND02
MalariaPf/PvRapidTestDevice
1
2017
100
Diagnostic
Enterprises
IRI21050
AdvantageMAL
Card
1
2022
0
1lotfailedRITMconfirmatorytestingin2022.
WHOLOTTESTINGPROGRAMMEFORMALARIARAPIDDIAGNOSTICTESTS(RDTs),(20072022)6
Manufacturer
CatalogueNo.
Productname
No.
lotstested
Year(s)tested
Pass
Ratet
(%)
Comment
(s)
DiamedAG
710024
OptiMAL-IT
1
2008
100
EdgeLabsLLP
EL011C25
EdgeXpressMalariaPanAntigenDetectionTest
3
2022
100
GuangzhouWondfoBiotechCo.Ltd.
W56-C(4.0mm)
OnestepMalariaPf/Panwholebloodtest
4
2008-2009
100
HemaDiagnostic
Systems,LCC
MAL-PFV-CAS25
Rapid1-2-3HemaCassetteMalaria(PFV)
3
2015
100
HumanGmbH
58024
HexagonMalaria
Combi
1
2008
0
1lotfailedinitialtestingin2008
ICTDiagnostics
ML02
ICTMalariaComboCassetteTest
68
2007-2008-
2009-2010-
2011-2012
88
8lotsfailedinitialtesting;2007(1),2008(1),2011(2)&2012(4)
ICTINTERNATIONAL
ML01
ICTMALARIAP.F.CASSETTETEST
249
2007-2008-
2009-2010-
2011-2014
100
ICTINTERNATIONAL
ML03
ICTMALARIADUALTEST
2
2012-2014
100
InnovitaBiologicalTechnologyCo.Ltd.
YF503C
MalariaPf/PanAntigenWholeBloodTestCassette(ColloidalGold)
2
2017-2018
50
1lotwasdeferredduringinitialtestingin2007.Noconfirmatorytestingresultavailable.
J.Mitra&Co.Pvt.Ltd.
IR016025
AdvantageP.f.
MalariaCard
15
2013-2014-
2015-2017-2018
100
J.Mitra&Co.Pvt.Ltd.
IR211025
AdvantageMalariaCard
1
2010
100
J.Mitra&Co.Pvt.Ltd.
IR231025
AdvantageMalariaPan+PfCard
4
2016-2018
100
Lumiquick
DiagnosticsInc.
71050
QuickProfile?
MalariaPf/Pv
AntigenTest
3
2013-2016
100
Lumiquick
Diagnostics,Inc.
71063
QuickProfile?MalariaPf/PanTest
2
2016
100
MerilDiagnostics,Pvt.Ltd.
MFLRDP-03
MeriScreenMalariaPf/PvAg
8
2020-2021-2022
100
NanongEgensBiotechnologyCo.,LTD.
Inf-73
MalariaP.f./Pv
AntigenTest
Cassette
2
2011-2013
100
NanongEgensBiotechnologyCo.,LTD.
Inf-76
MalariaP.f.AntigenTestCassette
2
2011-2013
100
WHOLOTTESTINGPROGRAMMEFORMALARIARAPIDDIAGNOSTICTESTS(RDTs),(20072022)7
Manufacturer
CatalogueNo.
Productname
No.
lotstested
Year(s)tested
Pass
Ratet
(%)
Comment
(s)
NanongEgensBiotechnologyCo.,LTD.
Nil
QDMalariaAntigenP.f
1
2014
100
OrchidBiomedicalSystems(TulipGroup)
30301025/302030010/302030025
ParacheckPf?
RapidTestforPf
Malaria(Ver.3)
1507
2007-2008-
2009-2010-
2011-2012-
2013-2014-
2015-2016-
2017-2018-
2019-2020-
2021-2022
100
PremierMedical
CorporationLtd.
I13FRC25/25CE/25S/30/30S/35
FirstResponse?MalariaAgP.falciparum(HRP2)CardTest
321
2009-2010-
2011-2012-
2013-2014-
2015-2016-
2017-2018-2019
100
PremierMedical
CorporationLtd.
I16FRC25/25CE/25S/30/30s/40
FirstResponse
Malaria
HRP2/pLDH(Pf/Pan)
172
2010-2011-
2012-2013-
2014-2015-
2016-2017-2018
99
Pvdetection@200parasites/μlfailedin2lotsin2015
PremierMedical
CorporationLtd.
I16MCC10/25
MalacheckMalariaAg(pLDH/HRP2)ComboCardTest
4
2012-2013
100
PremierMedical
CorporationLtd.
PI13FRC25/25CE/26/27/28
FirstResponse
MalariaAg.P.
falciparumHRP2
CardTest
294
2014-2016-
2017-2018-
2019-2020-
2021-2022
100
PremierMedical
CorporationLtd.
PI16FRC25/25CE/25S
FirstResponse
MalariaAg.
pLDH/HRP2ComboCardTest
112
2014-2017-
2018-2019-
2020-2021-2022
100
PremierMedicalCorporationPrivateLtd.
PI19FRC10/10S/25/25S
FirstResponse?MalariaAg.P.f./P.v.CardTest
47
2014-2017-
2019-2020-
2021-2022
96%
RapiGENInc.
C14RHG25
BIOCREDITMalariaAgPf(pLDH)
1
2021
100
RapiGENInc.
C32RHA25
BIOCREDITMalariaAgPf/Pan
(HRPII/pLDH)
4
2018-2020-2021
100
RapiGENInc.
C61RHI25
BIOCREDITMalariaPf/Pv
3
2021-2022
100
SDBiosensor,Inc.
09MAL10D
StandardQMalariaPfAg
78
2020-2021-2022
100
SDBiosensor,Inc.
09MAL20D
StandardQMalariaPf/PvAg
5
2020-2021-2022
100
SDBiosensor,Inc.
09MAL30D
StandardQMalariaPf/PANAg
20
2020-2021-2022
100
SDBioStandardDiagnosticsPVT.LTD,India
05FK60l-40
SDMalariaAg
Pf/Pan
2
2010
100
WHOLOTTESTINGPROGRAMMEFORMALARIARAPIDDIAGNOSTICTESTS(RDTs),(20072022)8
Manufacturer
CatalogueNo.
Productname
No.
lotstested
Year(s)tested
Pass
Ratet
(%)
Comment
(s)
ShenzhenBioeasyBiotechnologyCo.Ltd
YRLG0180102
BioeasyOneStepMalariaP.f/PanTriLineRapidTest
1
2019
100
StandardDiagnosticsInc.
05FK60/61/63/64/65/66/67
SDBIOLINEMalariaAgP.f/Pan
843
2010-2011-
2012-2013-
2014-2015-
2016-2017-
2018-2019-
2020-2021-2022
99
2lotsfailed
initialnon-
routine
testingin
2022.No
confirmatory
results
available.
StandardDiagnosticsInc.(Alere)
05FK120/123
SDBIOLINEMalariaAgP.f/P.f/P.v
43
2014-2015-
2016-2017-
2018-2019-2020
100
StandardDiagnosticsInc.(Alere)
05FK90/93
SDBIOLINEMalariaAgP.f(HRP2/pLDH)
136
2009-2010-
2012-2013-
2014-2015-
2016-2017-2018
-2019
100
Standard
Diagnostics,Inc.
05FK40
SDBiolineMalariaAg
14
2007-2008-
2009-2010
100
Standard
Diagnostics,Inc.
05FK50/51/52/53/54/55/56/57/58/59
SDBIOLINEMalariaAgPf
1846
2009-2010-
2011-2012-
2013-2014-
2015-2016-
2017-2018-
2019-2020-2021
100
2014-6lotsof05FK57failedintervaltestingduetoevaporationofbuffer
Standard
Diagnostics,Inc.
05FK80/81/83/85/86/87
SDBiolineMalariaAgP.f/P.v
474
2010-2011-
2012-2013-
2014-2015-
2016-2017-
2018-2019-
2020-2021-2022
100
Standard
Diagnostics,Inc.
05FK140
AlereMalariaAgPfUltraSensitive
5
2019-2020
100
TransasiaBio-
MedicalsLimited
132213
ErbaQik?MalariaPANAntigenTest
3
2022
0
3lotsfailedRITMconfirmatorytestingin2022.
ZephyrBiomedicals
503010025/10
Parascreen(FalciVax)DeviceRapidTestforMalariaPan/Pf(Device)
26
2007-2008-
2009-2010-
2020-2021
100
ZephyrBiomedicals
503030025
ParaScreenDeviceRapidTestforMalariaPAN
46
2020-2021-2022
100
ZephyrBiomedicals
503040025
ParaBankDeviceRapidTestforMalariaPAN/Pf
5
2020-2021
20
4lotsfailedconfirmatorytestingin2021
ZhuhaiEncodeMedicalEngineeringCo.,Ltd.
IMA432
RAPIQUICKMalariaP.f/PanRapidTestDevice
1
2017
0
1lotfailedinitialtestingin2017
WHOLOTTESTINGPROGRAMMEFORMALARIARAPIDDIAGNOSTICTESTS(RDTs),(20072022)9
Manufacturer
CatalogueNo.
Productname
No.
lotstested
Year(s)tested
Pass
Ratet
(%)
Comment
(s)
TOTAL
8129
tPassrateduringroutineinitialtesting
*PreviouslyknownasSpanDiagnosticsLtd
.
WHOLOTTESTINGPROGRAMMEFORMALARIARAPIDDIAGNOSTICTESTS(RDTs),(20072022)10
MALARIARDTLOTTESTINGRESULTSSUMMARY,2007–2022
From2013uptothelastlong-termtestingdonein2018,nolotshavefailed.Underinitialtesting,since2017nofailureswerenoteduntil2021.In2022,1lotfailedininitialtestingduetounacceptablyhighfalsepositiveagainstnegativeQCsamples.Intotal,8,258lotswereinitiallytestedwith17failures(0.22%)recordedfrom2007topresent.
Year
No.ofnew
products
No.ofnewmanufacturers
No.ofRDTs
lots
No.ofinitial
failures
No.oflongtermfailures
2007
8
7
59
1
1
2008
6
4
139
3
1
2009
2
-
243
0
2
2010
7
3
236
0
0
2011
4
2
365
2
9
2012
4
-
567
4
6
2013
6
1
1083
0
0
2014
2
1
927
0
0
2015
6
3
879
2
0
2016
14
2
797
1
0
2017
4
2
760
1
0
2018
2
1
592
0
0
2019
2
1
294
0
NA
2020
7
2
496
0
NA
2021
3
1
448
1
NA
2022
3
-
342
1
NA
Total
80
30
8258
1
19
WHOLOTTESTINGPROGRAMMEFORMALARIARAPIDDIAGNOSTICTESTS(RDTs),(20072022)11
PRE-QUALIFIEDPRODUCTSSUBMITTEDFORMALARIARDTLOT-TESTING,2022
In2022,theRITMreceived10lotsfrom5differentproductsthatwerenotincludedintheWHOPre-QualifiedListofMalariaRDTs(seelistbelow).Theselotsconstitutedalmost3%ofthetotallotsreceivedfortheyear;7werelot-testedforconfirmatory(fromNIMR)whilethe3weretestedforinitialtesting.
1.BIOCREDITMalariaAgPf/Pv;CatalogNumber-C61RHI25;Manufacturer-RapiGEN,Inc.
2.EzDxMalariaPan/PfRapidTestDetecti
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2024版星巴克加盟店設(shè)備維護(hù)合同
- 個(gè)人影視作品版權(quán)轉(zhuǎn)讓合同(2024版)3篇
- 2024示范文本:二手車買賣合同車輛安全檢測規(guī)范2篇
- 2024試乘試駕活動電子合同范本12篇
- 2025年度二手吊車評估與交易中介合同3篇
- 項(xiàng)目建議書(含設(shè)計(jì)任務(wù)書)及可行性研究報(bào)告編制技術(shù)咨詢合同模板
- 2025年度碼頭船舶??颗c貨物倉儲一體化租賃合同4篇
- 2025年度臨時(shí)醫(yī)療護(hù)理人員派遣服務(wù)合同4篇
- 2025年稅務(wù)顧問服務(wù)合同協(xié)議書適用于企業(yè)集團(tuán)6篇
- 眾維重工2025年度鋼結(jié)構(gòu)建筑工程智能化控制系統(tǒng)采購合同2篇
- 《穿越迷宮》課件
- 《C語言從入門到精通》培訓(xùn)教程課件
- 2023年中國半導(dǎo)體行業(yè)薪酬及股權(quán)激勵白皮書
- 2024年Minitab全面培訓(xùn)教程
- 社區(qū)電動車棚新(擴(kuò))建及修建充電車棚施工方案(純方案-)
- 項(xiàng)目推進(jìn)與成果交付情況總結(jié)與評估
- 鐵路項(xiàng)目征地拆遷工作體會課件
- 醫(yī)院死亡報(bào)告年終分析報(bào)告
- 建設(shè)用地報(bào)批服務(wù)投標(biāo)方案(技術(shù)方案)
- 工會工作人年度考核個(gè)人總結(jié)
- 上海民辦楊浦實(shí)驗(yàn)學(xué)校初一新生分班(摸底)語文考試模擬試卷(10套試卷帶答案解析)
評論
0/150
提交評論